Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes

Providence VA Medical Center

Status and phase

Completed

Phase 3

Conditions

Hypertension

Diabetes

Dyslipidemia

Treatments

Other: MEDIC

Study type

Interventional

Funder types

Other

Other U.S. Federal agency

Identifiers

NCT00409240

1127912

Details and patient eligibility

About

Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure.

Full description

Our project intends to study the 6-month efficacy of a pharmacist-led group intervention program that simultaneously target diabetes, hypertension and dyslipidemia. We hypothesize that pharmacist-led group interventions on a weekly basis for 4-weeks then on a monthly basis for 5 additional months may achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure. We are proposing a pilot randomized controlled study to test the efficacy and feasibility of this approach.

Enrollment

103 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

type 2 diabetes mellitus,
>18 years old,
with a documented HbA1c more than 7.0%,
an LDL cholesterol >100 mg/dl AND a blood pressure >130/80 mm Hg documented at least once in the medical records within the last 6 months, and
willing to comply with the study interventions will be eligible for the study.

Exclusion criteria

pregnancy,
unable to attend the group sessions,
disease conditions such as psychiatric instability (acutely suicidal, psychotic) or organic brain injury that preclude them from performing diabetes self-care,
enrolled in the Providence VAMC's Telehealth program